Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
Stopped early · Not applicable
Conditions studied: Bulimia Nervosa, Eating Disorders
In brief
This study will determine the effectiveness of administrating a dose of cholecystokinin during a binge eating episode in reducing this eating behavior in people with bulimia nervosa.
Key facts
- Study ID
- NCT00308776
- Run by
- New York State Psychiatric Institute
- People needed
- 6
- Starts
- 2003-10-01
- Expected to finish
- 2008-10-01
- Last updated by the study team
- 2012-05-28
Who can join
Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.
Where it is running
- New York State Psychiatric Institute — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.